Integra LifeSciences Holdings Corporation
IART
$14.05
-$0.14-0.99%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -484.07M | -25.29M | 19.44M | -10.70M | -12.40M |
| Total Depreciation and Amortization | 37.69M | 37.19M | 44.69M | 21.76M | 29.68M |
| Total Amortization of Deferred Charges | 1.89M | 1.39M | 1.40M | 1.34M | 1.46M |
| Total Other Non-Cash Items | 471.44M | 117.00K | -2.80M | 6.69M | 20.73M |
| Change in Net Operating Assets | -18.03M | -24.65M | -11.99M | 3.39M | 938.00K |
| Cash from Operations | 8.92M | -11.26M | 50.74M | 22.49M | 40.40M |
| Capital Expenditure | -20.15M | -28.92M | -29.60M | -29.65M | -29.71M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 4.18M | 0.00 | -281.99M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.50M | -7.00M | 21.17M | 19.25M | -10.50M |
| Cash from Investing | -21.65M | -35.92M | -4.25M | -10.40M | -322.20M |
| Total Debt Issued | 12.90M | 54.40M | 35.40M | 21.80M | 58.80M |
| Total Debt Repaid | -15.89M | -15.24M | -39.94M | -41.54M | -90.54M |
| Issuance of Common Stock | 0.00 | 957.00K | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -446.00K | -2.14M | -2.61M | -171.00K | -50.08M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -17.71M | -2.60M | 0.00 | 0.00 | -11.92M |
| Cash from Financing | -21.14M | 35.38M | -7.15M | -19.92M | -93.75M |
| Foreign Exchange rate Adjustments | 12.68M | 4.53M | -8.12M | 7.75M | -1.13M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.19M | -7.27M | 31.22M | -79.00K | -376.67M |